Quinidine: An "endangered species" drug appropriate for management of electrical storm in brugada syndrome

Stelios Paraskevaidis, Efstratios K. Theofilogiannakos, Vasileios Kamperidis, Yiannis S. Chatzizisis, Konstantinos Tsilonis, Vassilios P. Vassilikos, George Dakos, George Stavropoulos, Antonios Ziakas, Stavros Hadjimiltiades, Ioannis H. Styliadis

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Brugada syndrome is an inherited channelopathy associated with an increased risk of syncope and sudden cardiac death. In rare cases it can be manifested with electrical storm. We report two cases of Brugada syndrome that presented with electrical storm and were treated successfully with oral quinidine, an endangered species drug.

Original languageEnglish (US)
Pages (from-to)178-180
Number of pages3
JournalIndian Pacing and Electrophysiology Journal
Volume13
Issue number5
DOIs
StatePublished - 2013

Keywords

  • Brugada syndrome
  • Electrical storm
  • Quinidine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Quinidine: An "endangered species" drug appropriate for management of electrical storm in brugada syndrome'. Together they form a unique fingerprint.

  • Cite this

    Paraskevaidis, S., Theofilogiannakos, E. K., Kamperidis, V., Chatzizisis, Y. S., Tsilonis, K., Vassilikos, V. P., Dakos, G., Stavropoulos, G., Ziakas, A., Hadjimiltiades, S., & Styliadis, I. H. (2013). Quinidine: An "endangered species" drug appropriate for management of electrical storm in brugada syndrome. Indian Pacing and Electrophysiology Journal, 13(5), 178-180. https://doi.org/10.1016/S0972-6292(16)30670-2